Golden, CO, United States of America

George S Eisenbarth

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: George S Eisenbarth: Innovator in Autoimmunity Detection

Introduction

George S Eisenbarth, based in Golden, Colorado, is a notable inventor recognized for his groundbreaking contributions in the field of autoimmunity and diabetes diagnostics. With a total of three patents to his name, his work focuses on innovative methods to predict and manage autoimmune diseases, particularly Type 1 diabetes.

Latest Patents

Eisenbarth's most recent patent, "Methods for detecting insulin autoantibody," outlines techniques that can be utilized to assess the susceptibility to and diagnose the onset of Type 1 diabetes in subjects. This invention introduces kits designed for such detection methods, employing proinsulin as a key element in identifying insulin autoantibodies. Another significant invention titled "Compounds that modulate autoimmunity and methods of using the same" presents methods to prevent and treat autoimmune conditions, including diabetes and celiac disease. This innovation focuses on decreasing the affinity of MHC class II molecules to antigenic peptides, utilizing small organic compounds as therapeutic agents.

Career Highlights

Eisenbarth has made significant contributions while working at prestigious institutions such as the University of Colorado and the University of Florida Research Foundation. His research is paramount in advancing our understanding of autoimmune disorders and developing effective treatments.

Collaborations

Throughout his career, Eisenbarth has collaborated with esteemed colleagues, including Aaron Michels and Maki Nakayama. These collaborations have been instrumental in enhancing the research quality and broadening the impact of their findings in the scientific community.

Conclusion

George S Eisenbarth stands out as an influential figure in the realm of medical innovation, particularly in the diagnoses and treatment of autoimmune diseases. His advancements not only push the boundaries of scientific research but also pave the way for improved patient outcomes in managing Type 1 diabetes and related conditions. As he continues to innovate, his work remains a valuable asset to both the scientific and broader health communities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…